We are live on
!
Find out more
Amneal Pharmaceuticals
AMRX
AMRX
181 hedge funds and large institutions have $874M invested in Amneal Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 72 increasing their positions, 43 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
339% more call options, than puts
Call options by funds: $1.56M | Put options by funds: $355K
67% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 43
34% more capital invested
Capital invested by funds: $651M → $874M (+$223M)
21% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 29
9.87% more ownership
Funds ownership: 35.05% → 44.92% (+9.9%)
3% more funds holding
Funds holding: 176 → 181 (+5)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
181
Holders Change
+5
Holders Change %
+2.84%
% of All Funds
2.61%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
35
Increased
72
Reduced
43
Closed
29
Calls
$1.56M
Puts
$355K
Net Calls
+$1.2M
Net Calls Change
-$2.82M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$138M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$31.2M |
| 3 |
BlackRock
New York
|
+$13.4M |
| 4 |
HAI
Hennessy Advisors Inc
Novato,
California
|
+$8.82M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$7.49M |
